Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Joanna Krawczyk-Lipiec"'
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2890 (2022)
Sorafenib and lenvatinib are multi-targeted tyrosine kinase inhibitors which are currently approved to treat advanced hepatocellular carcinoma, renal cell carcinoma and radioiodine-refractory differentiated thyroid carcinoma. However this treatment i
Externí odkaz:
https://doaj.org/article/4bd0d0aeb67e460ab9d171ec817ca014
Publikováno v:
Contemporary Oncology, Vol 21, Iss 2, Pp 157-161 (2017)
Aim of the study . Cancer is usually associated with impaired nutritional status, which is one of the factors contributing to the deterioration of the results of surgery, chemotherapy, or radiotherapy. The aim of this study was the assessment of the
Externí odkaz:
https://doaj.org/article/c0980626b0dc4222be499f6c688ce8ca
Publikováno v:
Contemporary Oncology
Contemporary Oncology, Vol 21, Iss 2, Pp 157-161 (2017)
Contemporary Oncology, Vol 21, Iss 2, Pp 157-161 (2017)
Aim of the study . Cancer is usually associated with impaired nutritional status, which is one of the factors contributing to the deterioration of the results of surgery, chemotherapy, or radiotherapy. The aim of this study was the assessment of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a16af49edaa50ae8458b3322d74b775b
http://europepmc.org/articles/PMC5611506
http://europepmc.org/articles/PMC5611506
Publikováno v:
Biomedical reports. 7(2)
Neutropenia and febrile neutropenia (FN) are among the most common side effects/complications of chemotherapy. The aim of the present study was to evaluate the practice of the use of biosimilar filgrastim in the primary and secondary prevention of FN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c3350114526eadd2a97513279a26268
https://pubmed.ncbi.nlm.nih.gov/28804626
https://pubmed.ncbi.nlm.nih.gov/28804626
Publikováno v:
Clinical Nutrition. 37:S245-S246
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3e9338ac620a07f6e8cc648f6383b8d
https://doi.org/10.1016/j.clnu.2018.06.1869
https://doi.org/10.1016/j.clnu.2018.06.1869
Autor:
Andrzej Śliwczyński, Anna Waszczuk-Gajda, Lucjan Wyrwicz, Sebastian Rybski, Krzysztof Woźniak, Leszek Kraj, Joanna Krawczyk-Lipiec
Publikováno v:
Journal of Clinical Oncology. 35:e15756-e15756
e15756 Background: Preclinical studies have shown that calcium channel blockers (CCB) may potentiate anticancer effect of chemotherapy via intra-cellular drug accumulation. Gemcitabine-based chemotherapy is commonly used in pancreatic cancer (PC) pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::baed9f68b7832d12604ecdd572019213
https://doi.org/10.1200/jco.2017.35.15_suppl.e15756
https://doi.org/10.1200/jco.2017.35.15_suppl.e15756